People using Roche’s Accu-Chek SmartGuide continuous glucose monitoring (CGM) system will begin transitioning to the mySugr app, bringing glucose data, predictive insights and diabetes management tools together within a single platform.
The move follows Roche Diagnostics’ integration of the Accu-Chek SmartGuide and Accu-Chek SmartGuide Predict apps into the mySugr app – which now has more than seven million registered accounts worldwide.
A statement from the organisers:
We have received funding by means of sponsorship to support the delivery of the Diabetes Nursing Awards 2026. The sponsoring companies are embecta and Roche Diagnostics. Our sponsors have had no editorial input or control over the agenda, content development, choice of speakers or any influence in the results of the awards.
The winners of the Diabetes Nursing Awards 2026 were announced at a ceremony in Nottingham last night, recognising the outstanding achievements of diabetes nursing professionals from across the UK.
Held at The Orchard Hotel and Restaurant, the awards brought together finalists and healthcare colleagues for an evening celebrating excellence, innovation and dedication in diabetes care.
A statement from the organisers:
We have received funding by means of sponsorship to support the delivery of the Diabetes Nursing Awards 2026. The sponsoring companies are embecta and Roche Diagnostics. Our sponsors have had no editorial input or control over the agenda, content development, choice of speakers or any influence in the results of the awards.
NICE has issued final draft guidance recommending teplizumab for NHS reimbursement, positioning the drug as the UK’s first immunotherapy for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes.
Teplizumab is a humanised anti-CD3 monoclonal antibody and the first of an emerging class of disease modifying treatments. It is indicated to delay the onset of Stage 3 type 1 diabetes in adults and paediatric patients aged 8 years and older with Stage 2 type 1 diabetes.
The directors of the Diabetes Specialist Nurse (DSN) Forum UK have been recognised for their outstanding contributions to diabetes care with accolades at the Global Health Awards 2026.
Recognised for their commitment to advancing diabetes nursing practice, Amanda Williams, Bethany Kelly and Tamsin Fletcher-Salt were each presented with individual awards at a ceremony held on Thursday, July 9, at the House of Commons.
The importance of having a blood glucose monitor (BGM) alongside a continuous glucose monitor (CGM) was highlighted by a diabetes specialist dietitian in a recent online interview for the Diabetes Times.
John Pemberton, Registered Dietitian and Diabetes Specialist at Birmingham Women’s and Children’s NHS Foundation Trust, spoke with DT Editor Oliver Jelley in a special edition of the Big Interview, sponsored by Ascensia Diabetes Care.
The leaders of the NIHR ARC East Midlands demonstrated how UK researchers are working globally to tackle major health challenges and improve outcomes when they took centre stage in Ghana in April, leading a high-level, international dissemination event for the CREATE programme. To read more, click here.
A grieving father who vowed to prevent other families suffering the same heartbreak has secured ‘life-saving’ changes to the way type 1 diabetes is identified in children across England, following a relentless campaign launched after the death of his two-year-old daughter. To read more, click here.
An accreditation programme aimed at strengthening adult inpatient diabetes services is helping hospitals raise standards of care, according to a diabetes consultant. To read more, click here.
The question of whether clinical diabetic neuropathy can be reversed took centre stage at a formal debate during the 35th Annual Meeting of NEUROdiab last year. To read more, click here.
A major conference which has a new direction to advance collaboration across cardiovascular, renal and metabolic care has announced the first experts joining its speaker line-up for 2026.
Dr Kevin Fernando, Portfolio GP with an Extended Role in Diabetes, Dr Lisa Anderson, Consultant Cardiologist, and Dr Andrew Frankel, Consultant Physician and Nephrologist, are among the first speakers confirmed for CVRM Professional Care, taking place at Olympia in London on October 20 and 21.
Hypo Awareness Week 2026 has been funded by Roche, which has had no input into the campaign’s arrangements or content.
We anticipate that the campaign will receive further sponsorship from pharmaceutical companies and medical technology companies. Once confirmed it will be added to the relevant pages of the Hypo Awareness Week website and Hypo Awareness Week promotional materials, where appropriate.
Roche Diagnostics has been confirmed as an official sponsor of Hypo Awareness Week 2026. To read more, click here.
A book challenging glucose-centric type 1 diabetes management has been published by a doctor living with the condition. To read more, click here.
"No one ever told me that grief felt so like fear." What is grief? I have previously read about it, seen other people go through it, even been through it myself. Yet, at the present moment of time the sheer intensity of going through it every day has been scorching for the soul, the mind and perhaps even the body. Suffocating, relentless, like a vice around you. To read more, click here.
Bringing you the latest jobs from around the country within the field of diabetes.
Consultant Diabetes, Endocrinology & General Medicine – Croydon Health Services NHS Trust
Diabetes Podiatrist – Northumbria Healthcare NHS Foundation Trust
Specialist Diabetes Dietitian – Hertfordshire Community NHS Trust
Diabetes Specialist Nurse – Worcestershire Acute Hospitals NHS Trust
Join the expanding diabetes community on X and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
